Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

已取消 100 由达姆发布于 2026/7/1 11:01:16

DOI:10.23736/S0026-4806.25.09852-0
作者：Mariana L Maximiano,?Ocílio R Gon?alves,?Luciano Falc?o,?Jo?o V Fernandes,?Kenzo O Donato,?Filipe V Ribeiro,?Marianna Leite,?Lucca T Carretta,?Rafael F Santos,?Luiz G Almeida,?Milene V Sobral,?Jo?o P
文献类型：期刊论文
补充材料：只需要正文

Minerva Medica

Abstract：Background: Recombinant human prourokinase (rhPro-UK) has been investigated as an alternative thrombolytic agent to alteplase for acute ischemic stroke (AIS). While alteplase remains the sta

应助信息

5小时前

Book学术机器人

2026/7/1 11:01:17 未找到该文献，机器人已退出，请等待人工下载

2026/7/1 11:01:17 Book学术AI机器人收到请求，开始寻找文献

2026/7/1 11:01:17 已向机器人发送请求

5小时前

达姆发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Royal Society of Chemistry (RSC)Efficient and stable electrochemical carbon capture via integrated CO2 absorption and regeneration